HealthStream , a leading provider of workforce and provider solutions for the healthcare industry, today announced that its Board of Directors has approved an expansion of its share repurchase program for the Company’s common stock, under which the Company may repurchase up to an additional $10 million of outstanding shares of common stock. The Company previously repurchased the $20 million of common stock authorized under the share repurchase program announced on November 30, 2021.

Lightbeam Health Solutions, the leader in end-to-end population health management solutions and services, today announces that Spectrum Health will be joining the Lightbeam Health team at booth #1721 during HIMSS 2022, taking place March 14-18 at the Orange County Convention Center in Orlando, FL. Representatives from Spectrum will be onsite to promote the results of a new patient impact story and case study facilitated by Lightbeam. In 2021, Spectrum deployed a new pilot program fo

New research from Accenture and HIMSS Market Insights reveals that 93% of U.S. healthcare executives believe that health equity initiatives are important and 89% agree that such initiatives are part of their core business strategy. However, only slightly more than a third (36%) have a specific budget dedicated to advancing their health equity agendas. “The pandemic awakened the world to the realities of inequality that have existed for generations in our health care system,&rd

AIDS Healthcare Foundation  applauds the European Union (EU), South Africa, India and the US for reaching a compromise on waiving intellectual property protection on COVID -19 vaccines, according to POLITICO . AHF urges all EU countries and World Trade Organization member states to immediately ratify and implement the proposal to accelerate global access to vaccines. “While this compromise is woefully late, as South Africa and India proposed an intellectual property waive

CliniComp introduces and announces the installation of its wireless data acquisition system, nDAS, for the Veterans Integrated Service Network (VISN) 17, VA Heart of Texas Health Care Network. The nDAS installation expands current data acquisition capabilities by providing caregivers with mobile continuity of ventilator and other medical device integration throughout the hospital. CliniComp's wireless data acquisition system eliminates barriers to safe, accurate, and seamless da

Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system. “Though everyone is familiar with IV pump delivery systems used to administer medications during a patient’s hospital stay, improvements in technology have allowed us to do it in a controlled and measured way,” said Rita Zenna, RN, Deborah’s Vice President for Patient Care Services. “This is why we replaced our existing pumps wi

Rockley Photonics Holdings Limited, a global leader in photonics-based health monitoring and communications solutions, today announced that it has agreed to enter a development partnership with Medtronic, a global leader in healthcare technology. The two companies plan to collaborate to bring Rockley’s recently announced Bioptx™ biomarker sensing platform into Medtronic’s solutions for use across various healthcare settings. Rockley’s biosensing technology is

HeartBeam, Inc., a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a professional services agreement (the “Agreement”) with Triple Ring Technologies, Inc. (“Triple Ring”), a co-development company, to assist in the design and development of its Telehealth complete solution 3D vector Electrocardiogram (ECG) collection device for remote heart attack or myocardial infar

C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022. This latest expansion aligns with C2Dx's strategy to invest in and refine the delivery of valuable niche products to propel their growth and accessibility worldwide. The acquisition of Hemostatix will mean the integration of the thermal scalpel system, employees, and customer contracts all operating under C2Dx. Product manufacturing and

As part of an ongoing multi-center study, Fluidx Medical released additional information on treating tumors including a highly vascularized metastatic renal cell carcinoma with the GPX Embolic Device. "We were very pleased with the outcome and the resulting occlusion created by GPX," said Martin Krauss, M.D., Head of Interventional Radiology, Christchurch Hospital, Christchurch, New Zealand.  "In one procedure, the renal cell carcinoma had metastasized to the upp